z-logo
open-access-imgOpen Access
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy
Author(s) -
Simone Belmonti,
Francesca Lombardi,
Eugenia Quirós-Roldán,
Alessandra Latini,
Antonella Castagna,
Alberto Borghetti,
Gianmaria Baldin,
Arturo Ciccullo,
Roberto Cauda,
Andrea De Luca,
Simona Di Giambenedetto,
Andrea Giacometti,
Massimo Di Pietro,
Maria Teresa Mughini,
Pierfrancesco Grima,
Claudio Viscoli,
Paolo Emilio Manconi,
Massimo Puoti,
Massimo Galli,
Pierluigi Viale,
Andrea Gori,
Giuliano Rizzardini,
Maurizio Mineo,
Andrea Antinori,
Nicola Petrosillo,
Vincenzo Vullo,
María Stella Mura,
Pietro Caramello,
Pier Giorgio Scotton,
Ercole Concia,
Adriano Lazzarin,
Daniela Francisci,
D. Sacchini
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky125
Subject(s) - atazanavir , medicine , ritonavir , lamivudine , biomarker , viral load , c reactive protein , gastroenterology , inflammation , randomized controlled trial , oncology , antiretroviral therapy , immunology , human immunodeficiency virus (hiv) , hepatitis b virus , biochemistry , virus , chemistry
Biomarkers of systemic inflammation predict non-AIDS events and overall mortality in virologically suppressed HIV-1-infected patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom